Evidence-Based Medicine Guidelines
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Cardiovascular Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455821/all/Platelet_glycoprotein_IIb_IIIa_receptor_antagonists_in_cardiovascular_disease.
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455821/all/Platelet_glycoprotein_IIb_IIIa_receptor_antagonists_in_cardiovascular_disease. Accessed May 30, 2023.
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455821/all/Platelet_glycoprotein_IIb_IIIa_receptor_antagonists_in_cardiovascular_disease
Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Cardiovascular Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 May 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455821/all/Platelet_glycoprotein_IIb_IIIa_receptor_antagonists_in_cardiovascular_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease
ID - 455821
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455821/all/Platelet_glycoprotein_IIb_IIIa_receptor_antagonists_in_cardiovascular_disease
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
